-
THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS IN ADULT AND PEDIATRIC HEALTHCARE SERVICES IN TURKIYE: FINDINGS FROM A SURVEY OF PHYSICIANS AND HEALTHCARE PROFESSIONALS
Aug 11, 2026, 17:16 PM -
EVALUATING THE CLINICAL AND ECONOMIC IMPACT OF PLASMA PTAU217 TESTING IN THE SWISS ALZHEIMER'S DISEASE DIAGNOSTIC PATHWAY
Aug 11, 2026, 17:16 PM -
INFLAMMATORY AND METABOLIC BURDEN OF MASLD AND ALCOHOL-OVERLAP STEATOTIC LIVER DISEASE IN SOUTH KOREA
Aug 11, 2026, 17:16 PM -
TRAJECTORIES AND COMPOSITION OF COSTS ACROSS DISEASE PROGRESSION STAGES IN DUCHENNE MUSCULAR DYSTROPHY: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
CHARACTERISTICS AND TREATMENT PATTERNS OF A REAL-WORLD COHORT OF PATIENTS WITH ADVANCED HER2-MUTANT NSCLC: INSIGHTS FROM THE ESME DATABASE
Aug 11, 2026, 17:16 PM -
ANNUAL DIRECT MEDICAL COST OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES IN TURKIYE: A PUBLIC PAYER MICRO-COSTING ANALYSIS
Aug 11, 2026, 17:16 PM -
WHY TWO BRANDS FOR ONE MOLECULE? STRATEGIC IMPLICATIONS OF DUAL-BRAND APPROACHES FOR ORPHAN DESIGNATIONS, REVENUE THRESHOLDS AND PRICING IN GERMANY
Aug 11, 2026, 17:16 PM -
SYSTEMATIC LITERATURE REVIEW AND CRITICAL APPRAISAL OF COST-EFFECTIVENESS MODELS OF ANTIMICROBIAL TREATMENTS
Aug 11, 2026, 17:16 PM -
REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN ADVANCED/METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITH AND WITHOUT ACTIONABLE GENOMIC ALTERATIONS: A POPULATION-BASED COHORT STUDY IN ENGLAND, 2017-2025
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATIONS OF NON-PHARMACOLOGIC MANAGEMENT FOR CONGESTIVE HEART FAILURE: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
INCLUSION OF CAREGIVER QUALITY-OF-LIFE IN ECONOMIC EVALUATIONS: GLOBAL HTA PERSPECTIVES AND IMPACT
Aug 11, 2026, 17:16 PM -
HOW CAN WE APPROACH WHOLE HEALTH USING DIGITAL BIOMARKERS AND ENDPOINTS FROM CONSUMER WEARABLES?
Aug 11, 2026, 17:16 PM -
AGREEMENT BETWEEN ARTIFICIAL INTELLIGENCE AND HUMAN ASSESSMENT IN QUALITY APPRAISAL OF ECONOMIC EVALUATIONS USING THE DRUMMOND CHECKLIST
Aug 11, 2026, 17:16 PM -
A DISCRETE EVENT SIMULATION MODEL FOR THE HEALTH ECONOMIC EVALUATION OF A RAPID AI-GUIDED WHOLE-GENOME SEQUENCING PLATFORM FOR THE DIAGNOSIS OF ESKAPEE BLOODSTREAM INFECTIONS: MODEL DEVELOPMENT AND METHODOLOGY
Aug 11, 2026, 17:16 PM -
PROJECTING THE FUTURE BURDEN OF NON-MUSCLE INVASIVE BLADDER CANCER IN EUROPE: AN EPIDEMIOLOGICAL MODEL FRAMEWORK BASED ON REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
ASSESSING THE REAL-WORLD EFFECTIVENESS OF SPESOLIMAB IN GENERALIZED PUSTULAR PSORIASIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
ASSESSING HEALTH-RELATED QUALITY OF LIFE AMONG CHILDREN AND ADOLESCENTS WITH VISION IMPAIRMENT USING THE EQ-5D-Y-3L INSTRUMENT IN BRAZIL
Aug 11, 2026, 17:16 PM -
HOW MUCH DO MEDICATIONS COST PATIENTS IN FINLAND? A NATIONWIDE REGISTER-BASED STUDY OF OUT-OF-POCKET COSTS
Aug 11, 2026, 17:16 PM -
CURRENT TREATMENT PATTERNS AND SAFETY OUTCOMES IN RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) WITH AN NPM1 MUTATION: A SYSTEMATIC LITERATURE REVIEW (SLR)
Aug 11, 2026, 17:16 PM -
COSTS AND COST DRIVERS OF INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM: EVIDENCE FROM A LARGE PATIENT SURVEY USING TWEEDIE REGRESSION
Aug 11, 2026, 17:16 PM
